miscellanea

Response to: 'Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease' by Orlando et al

Gaëlle Varkas, Filip Van den Bosch, Dirk Elewaut Published in 2017 in London by Bmj Publishing Group

Reference details